142 related articles for article (PubMed ID: 21392056)
1. Management of drooling in children: a survey of UK paediatricians' clinical practice.
Parr JR; Buswell CA; Banerjee K; Fairhurst C; Williams J; O'Hare A; Pennington L;
Child Care Health Dev; 2012 Mar; 38(2):287-91. PubMed ID: 21392056
[TBL] [Abstract][Full Text] [Related]
2. Drooling Reduction Intervention randomised trial (DRI): comparing the efficacy and acceptability of hyoscine patches and glycopyrronium liquid on drooling in children with neurodisability.
Parr JR; Todhunter E; Pennington L; Stocken D; Cadwgan J; O'Hare AE; Tuffrey C; Williams J; Cole M; Colver AF
Arch Dis Child; 2018 Apr; 103(4):371-376. PubMed ID: 29192000
[TBL] [Abstract][Full Text] [Related]
3. Glycopyrrolate for chronic drooling in children.
Eiland LS
Clin Ther; 2012 Apr; 34(4):735-42. PubMed ID: 22445330
[TBL] [Abstract][Full Text] [Related]
4. The drooling reduction intervention trial (DRI): a single blind trial comparing the efficacy of glycopyrronium and hyoscine on drooling in children with neurodisability.
Parr JR; Weldon E; Pennington L; Steen N; Williams J; Fairhurst C; O'Hare A; Lodh R; Colver A
Trials; 2014 Feb; 15():60. PubMed ID: 24533890
[TBL] [Abstract][Full Text] [Related]
5. Glycopyrrolate for drooling in children with medical complexity under three years of age.
Lovardi E; De Ioris MA; Lettori D; Geremia C; Staccioli S; Bella GD; Scrocca R; Scarselli A; Aversa M; De Peppo F; Campana A; Castelli E
Ital J Pediatr; 2022 Jan; 48(1):2. PubMed ID: 34998418
[TBL] [Abstract][Full Text] [Related]
6. Effect of botulinum toxin in the treatment of drooling: a controlled clinical trial.
Jongerius PH; van den Hoogen FJ; van Limbeek J; Gabreëls FJ; van Hulst K; Rotteveel JJ
Pediatrics; 2004 Sep; 114(3):620-7. PubMed ID: 15342830
[TBL] [Abstract][Full Text] [Related]
7. The management of drooling in adults with neurological conditions.
Squires N; Wills A; Rowson J
Curr Opin Otolaryngol Head Neck Surg; 2012 Jun; 20(3):171-6. PubMed ID: 22487791
[TBL] [Abstract][Full Text] [Related]
8. Preliminary study of glycopyrrolate in the management of drooling.
Stern LM
J Paediatr Child Health; 1997 Feb; 33(1):52-4. PubMed ID: 9069045
[TBL] [Abstract][Full Text] [Related]
9. Anticholinergic medications for reducing drooling in children with developmental disability.
Reid SM; Westbury C; Guzys AT; Reddihough DS
Dev Med Child Neurol; 2020 Mar; 62(3):346-353. PubMed ID: 31495925
[TBL] [Abstract][Full Text] [Related]
10. [Drooling therapy in children with neurological disorders].
Táboas-Pereira MA; Paredes-Mercado C; Alonso-Curcó X; Badosa-Pagès J; Muchart J; Póo P
Rev Neurol; 2015 Jul; 61(2):66-70. PubMed ID: 26156441
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological interventions for treating sialorrhea associated with neurological disorders: A mixed treatment network meta-analysis of randomized controlled trials.
Sridharan K; Sivaramakrishnan G
J Clin Neurosci; 2018 May; 51():12-17. PubMed ID: 29475576
[TBL] [Abstract][Full Text] [Related]
12. Randomized trial of botulinum toxin injections into the salivary glands to reduce drooling in children with neurological disorders.
Reid SM; Johnstone BR; Westbury C; Rawicki B; Reddihough DS
Dev Med Child Neurol; 2008 Feb; 50(2):123-8. PubMed ID: 18201301
[TBL] [Abstract][Full Text] [Related]
13. Glycopyrronium for severe drooling in children.
Drug Ther Bull; 2017 Aug; 55(8):93-96. PubMed ID: 28808084
[TBL] [Abstract][Full Text] [Related]
14. Drooling in children with cerebral palsy: effect of salivary flow reduction on daily life and care.
Van der Burg JJ; Jongerius PH; Van Hulst K; Van Limbeek J; Rotteveel JJ
Dev Med Child Neurol; 2006 Feb; 48(2):103-7. PubMed ID: 16417664
[TBL] [Abstract][Full Text] [Related]
15. [Survey on awareness of violence against children and the use of the guide "violence against children and young people" by paediatricians in Brandenburg].
Ellsässer G; Cartheuser C
Gesundheitswesen; 2006 Apr; 68(4):265-70. PubMed ID: 16705563
[TBL] [Abstract][Full Text] [Related]
16. Surgical management of drooling: clinical and caregiver satisfaction outcomes.
Stamataki S; Behar P; Brodsky L
Int J Pediatr Otorhinolaryngol; 2008 Dec; 72(12):1801-5. PubMed ID: 18848362
[TBL] [Abstract][Full Text] [Related]
17. Compounded glycopyrrolate is a compelling choice for drooling children: five years of facility experience.
Zanon D; Tumminelli C; Galimberti AMC; Torelli L; Maestro A; Barbi E; Maximova N
Ital J Pediatr; 2021 Nov; 47(1):222. PubMed ID: 34742343
[TBL] [Abstract][Full Text] [Related]
18. Prescribing of psychotropic medication to the intellectually disabled by community paediatricians - a survey.
Elliott SJ; Haider BB
Child Care Health Dev; 2009 Nov; 35(6):826-31. PubMed ID: 19438877
[TBL] [Abstract][Full Text] [Related]
19. Social interaction and self-esteem of children with cerebral palsy after treatment for severe drooling.
van der Burg JJ; Jongerius PH; van Limbeek J; van Hulst K; Rotteveel JJ
Eur J Pediatr; 2006 Jan; 165(1):37-41. PubMed ID: 16172877
[TBL] [Abstract][Full Text] [Related]
20. The use of botulinum toxic injection to treat excessive drooling in children with neurological conditions.
Khan A; Pawar G
W V Med J; 2005; 101(6):258-60. PubMed ID: 16625812
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
